.jpg)
- ACTA RADIOLOGICA
-
影響因子：
1.33
-
I S S N：
0284-1851
-
出 版 社：
Royal Society of Medicine Press
-
出 版 地：
London
-
出版國(guó)家：
England
-
刊 期：
雙月刊
-
創(chuàng)刊時(shí)間：
1987
-
語(yǔ) 種：
英文
-
審稿周期：
一般,3-8周
-
中科院分區(qū)：
4
-
投稿命中率：
容易
-
國(guó)外數(shù)據(jù)庫(kù)收錄：
IM
-
中國(guó)收錄文章數(shù)：
34
-
5年影響因子：
1.454
-
研究領(lǐng)域：
放射核醫(yī)學(xué)
-
官方鏈接：
http://informahealthcare.com/loi/ard
-
投稿須知：
http://informahealthcare.com/loi/ard
期刊介紹：
In consideration of the National Institutes of Health (NIH) and Wellcome Public and Open Access Policies, the Informa Healthcare journals group acknowledges that the broad and open dissemination of NIH/Wellcome-funded research results may benefit future scientific and medical research. Because we value the current and future contributions our journals make to the scientific body of knowledge, we have made certain that our policies accommodate NIH- and Wellcome-funded authors who are required to submit to PubMed Central. NIH/Wellcome-funded authors are invited to submit their funded work to PMC/UKPMC themselves providing they submit only the final peer-reviewed manuscript which was accepted for publication (post-print) (this manuscript must not be altered by Publisher's copyediting and typesetting services) and stating the 12-month (NIH) or 6-month (Wellcome Trust) embargo period after final publication. Following the deposit, authors will receive further communications from the NIH Manuscript Submission System/UK Manuscript Submission System with respect to the submission
